Bladder Cancer Trial, Recruiting NCT06269536 Sponsor: Comenius University Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06269536
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be older than 18 years of age.
  • You must have been diagnosed with a type of bladder cancer (urothelial carcinoma, including certain variations) confirmed by a biopsy showing the cancer has grown into the muscle of the bladder wall.
  • You must not have received any chemotherapy treatment before joining the trial.
  • You must have no history of other cancers, except for a common type of skin cancer (basal-cell carcinoma) diagnosed within the last 5 years.
  • Your kidneys must be working well enough, as measured by a specific kidney function test showing results above a certain level (confirm with trial site).
  • Your blood counts and liver markers must be within acceptable ranges, including white blood cells, platelets, and a substance called bilirubin (confirm with trial site for exact values).
  • Your liver must be functioning adequately overall.
  • You must have basic computer skills.
  • You must be willing and able to sign a consent form agreeing to take part in the trial.

Who may not be able to join:

  • You may not be eligible if you have diabetes that has caused nerve damage with noticeable symptoms.
  • You may not be eligible if you are currently taking medications for heart rhythm problems, strong pain relief (opioids), or antidepressants.
  • You may not be eligible if you have a permanent pacemaker fitted in your body.
  • You may not be eligible if you have an HIV infection.
  • You may not be eligible if you do not meet all of the inclusion criteria listed above.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Patrik Palacka, Faculty of Medicine, Comenius University in Bratislava

Phone: +421290119943

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Comenius University
Registry
ClinicalTrials.gov
Start date
15 February 2024
Est. completion
15 February 2027

Where this trial is recruiting

🇸🇰 Slovakia

Primary endpoints

Primary Objective: Inflammation; Primary Objective: Heart Rate Variability (HRV); Primary Objective: Quality of Life (QoL); Primary Objective: Working memory; Primary objective: Executive function; Primary objective: Salivary Cortisol Slopes; Primary objective: Sleep Quality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov